In collaboration with leading integrin drug developers, including Genentech, 7 Hills Pharma, and Pfizer, the 2nd Integrin-Targeted Drug Development Summit is designed for industry leaders to ...

A remarkable development in breast cancer research has revealed a fundamental mechanism behind driving cancer invasion and ...

A significant breakthrough in breast cancer research has uncovered a key mechanism driving cancer invasion and drug ...

This year, it has been joined by natalizumab (Tysabri; Elan/Biogen-Idec), a humanized antibody against α4 integrin ... and the drug label contains a black-box warning of the risk of serious ...

These proteins, HER2 and aVb6 integrin, are already known to independently predict cancer outcomes ... As a result, the ...

New research uncovers key insights into breast cancer progression and drug resistance, paving the way for more effective ...

These proteins, HER2 and αVβ6 integrin, are already known to independently ... more invasive through alternative pathways, meaning drugs designed to block αVβ6 or HER2 no longer prevent ...